Concepedia
Statistics
Publications
5
Citations
97
H-Index
Active since
2001
Affiliations
National Cancer Institute(Current)
Children's Hospital of Philadelphia
Children's Cancer Center
B. C. Widemann is an author at National Cancer Institute specializing in medicine, cancer research, and oncology.
Top concepts
MedicineOncologyCancer ResearchPathologyPediatricsPharmacologyCancer TherapyPharmacotherapyMolecular OncologyRadiation Oncology
Publications per year
2001–2009
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101
Peter C. Adamson, Susan M. Blaney, B. C. Widemann et al. · Cancer Chemotherapy and Pharmacology · 2004 · 30 citations
Thrombopoiesis, Thrombosis, Growth Hormone +9
A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.
Peter C. Adamson, B. C. Widemann, Gregory H. Reaman et al. · PubMed · 2001 · 20 citations
Phase I/II trial of vandetanib in children and adolescents with hereditary medullary thyroid carcinoma
Elizabeth Fox, B. C. Widemann, Patricia Whitcomb et al. · Journal of Clinical Oncology · 2009 · 17 citations
Pathology, Linear Growth, Type 2B +17
Phase I study of sorafenib in children with refractory solid tumors: A Children's Oncology Group Phase I Consortium trial
B. C. Widemann, Elizabeth Fox, Peter C. Adamson et al. · Journal of Clinical Oncology · 2009 · 16 citations
Surgical Oncology, Cancer Management, Sorafenib Auc +16
Clinical Drug Development for Childhood Cancers
Elizabeth Fox, B. C. Widemann, P. C. Adamson · Clinical Pharmacology & Therapeutics · 2009 · 14 citations · Full text
Medicine, Pediatrics, Anti-cancer Agent +6
1–5 of 5